Search

Your search keyword '"Lia Elena Perez"' showing total 13 results
Start Over Author "Lia Elena Perez"
13 results on '"Lia Elena Perez"'

1. Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience

Author

Filip Ionescu, Eloho Ajayi, Aamia Leach, Melissa Alsina, Nelli Bejanyan, Omar Castaneda, Hany Elmariah, Ciara Freeman, Doris K Hansen, Michael D Jain, Farhad Khimani, Aleksandr Lazaryan, Hien Liu, Frederick L. Locke, Asmita Mishra, Dr. Michael L. Nieder, Leonel Ochoa, Lia Elena Perez, Joseph A. Pidala, Rod Quilitz, Olga V Klinkova, Aliyah Baluch, Taiga Nishihori, and Rawan G Faramand

Subjects
Transplantation, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology
Published
2023

2. Phase I Trial of CD8-Depleted Human Leukocyte Antigen (HLA) Mismatched Unrelated Donor Lymphocyte Infusion (DLI) to Achieve Remissions in Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukemia (sAML)

Author

Hany Elmariah, Jongphil Kim, Kayla Reid, Christopher Cubitt, Jeffrey E Lancet, Andrew T Kuykendall, Rami Komrokji, David Sallman, Onyee Chan, Kendra Sweet, Albert Ribickas, Rawan G Faramand, Asmita Mishra, Farhad Khimani, Lia Elena Perez, Kedar Kirtane, Stephanie Dormesy, Debra Kessler, Doris K Hansen, Joseph A. Pidala, Claudio Anasetti, Ephraim J. Fuchs, Michael D Jain, Frederick L. Locke, Nelli Bejanyan, and Amy E. DeZern

Subjects
Transplantation, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology
Published
2023

3. Impact of Obesity and Chemotherapy Dosing on Allogeneic Hematopoietic Cell Transplant Outcomes for Myelodysplastic Syndrome (MDS)

Author

Omar Albanyan, Syeda Mahrukh Naqvi, Qianxing Mo, Athena Belfon, Eric Gaskill, Taiga Nishihori, Rawan G Faramand, Aleksandr Lazaryan, Doris K Hansen, Farhad Khimani, Asmita Mishra, Dr. Michael L. Nieder, Lia Elena Perez, Hien Liu, Joseph A. Pidala, Claudio Anasetti, Frederick L. Locke, Nelli Bejanyan, and Hany Elmariah

Subjects
Transplantation, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology
Published
2023

4. Developing Contemporary Survivorship Clinic for Recipients of Hematopoietic Cell Transplantation: A Single Center Experience

Author

Razan Mohty, Taiga Nishihori, Rawan G Faramand, Doris K Hansen, Dr. Michael L. Nieder, Aleksandr Lazaryan, Laura Besaw, Meredith Tate Smith, Jolene Rowe, Asmita Mishra, Joseph A. Pidala, Nelli Bejanyan, Melissa Alsina, Farhad Khimani, Omar Castaneda Puglianini, Lia Elena Perez, Hany Elmariah, Michael D Jain, Jose Leonel Ochoa-Bayona, Frederick L. Locke, and Hien Liu

Subjects
Transplantation, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology
Published
2023

5. CD40 Ligand Blockade Prevents Acute Gvhd: Results from a Multicenter Phase I-Ib Trial

Author

Farhad Khimani, Haris Ali, Brian C. Betts, Jongphil Kim, Hany Elmariah, Lia Elena Perez, Taiga Nishihori, Christopher Cubitt, Michael L. Nieder, Nelli Bejanyan, Frederick L. Locke, Melissa Alsina, Rawan G Faramand, Asmita Mishra, Michael D Jain, Aleksandr Lazaryan, Leonel Ochoa, Doris K Hansen, Omar Castaneda, Ciara Freeman, Marco L. Davila, Hien Liu, Ram Thapa, Claudio Anasetti, Hannah Choe, and Joseph A. Pidala

Subjects
Transplantation, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology
Published
2022

6. Impact of Obesity on Lymphodepletion and Outcomes Following Idecabtagene Vicleucel in Multiple Myeloma

Author

Doris K Hansen, Alexandria M Shrewsbury, Lauren Peres, Jessica Provencher, Taiga Nishihori, Hien Liu, Jason Brayer, Omar Castaneda, Brandon Jamaal Blue, Leonel Ochoa, Ciara Freeman, Jennifer Logue, Hany Elmariah, Rawan G Faramand, Michael D Jain, Aleksandr Lazaryan, Nelli Bejanyan, Lia Elena Perez, Michael L. Nieder, Asmita Mishra, Joseph A. Pidala, Marco L. Davila, Kenneth Shain, Rachid Baz, Frederick L. Locke, and Melissa Alsina

Subjects
Transplantation, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology
Published
2022

7. Cytopenia and Infection Early after Standard of Care Idecabtagene Vicleucel in Multiple Myeloma

Author

Jennifer Logue, Lauren Peres, Alexandria M Shrewsbury, Jessica Provencher, Taiga Nishihori, Hien Liu, Jason Brayer, Omar Castaneda, Brandon Jamaal Blue, J. Leonel Ochoa-Bayona, Ciara Freeman, Hany Elmariah, Rawan G Faramand, Michael D Jain, Aleksandr Lazaryan, Nelli Bejanyan, Lia Elena Perez, Michael L. Nieder, Asmita Mishra, Joseph A. Pidala, Marco L. Davila, Kenneth Shain, Rachid Baz, Melissa Alsina, Frederick L. Locke, and Doris K Hansen

Subjects
Transplantation, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology
Published
2022

8. Multivirus-Specific T-Cell Therapy with Posoleucel (ALVR105) for Refractory Disseminated Adenovirus Infection after Allogeneic HCT

Author

Asmita Mishra, Olga V Klinkova, Aliyah Baluch, Nelli Bejanyan, Marian Dam, Hany Elmariah, Susan Ferrey, Farhad Khimani, Michael L. Nieder, Taiga Nishihori, J. Leonel Ochoa-Bayona, Lia Elena Perez, Joseph A. Pidala, Seung Hyun Moon, and Rawan G Faramand

Subjects
Transplantation, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology
Published
2022

9. Measurable Residual Disease Outcompetes Cytogenetics in Predicting Leukemia Free Survival Following Allogeneic Stem Cell Transplantation Outcomes in Adults with Acute Lymphoblastic Leukemia

Author

Rawan G Faramand, Biwei Cao, Abu-Sayeef Mirza, Jongphil Kim, Silvia Tse Bunting, Omar Castaneda, Marco L. Davila, Hany Elmariah, Ciara Freeman, Doris K Hansen, Michael D Jain, Farhad Khimani, Frederick L. Locke, Hien Liu, Joseph A. Pidala, Leonel Ochoa, Asmita Mishra, Michael L. Nieder, Taiga Nishihori, Melissa Alsina, Lia Elena Perez, Bijal Shah, Claudio Anasetti, Nelli Bejanyan, and Aleksandr Lazaryan

Subjects
Transplantation, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology
Published
2022

10. Marrow Myeloma Burden and Idecabtagene Vicleucel Outcomes in the Standard of Care Setting

Author

Doris K Hansen, Alexandria M Shrewsbury, Lauren Peres, Jessica Provencher, Taiga Nishihori, Hien Liu, Jason Brayer, Omar Castaneda, Brandon Jamaal Blue, Leonel Ochoa, Ciara Freeman, Jennifer Logue, Hany Elmariah, Rawan G Faramand, Michael D Jain, Aleksandr Lazaryan, Nelli Bejanyan, Lia Elena Perez, Michael L. Nieder, Asmita Mishra, Joseph A. Pidala, Marco L. Davila, Kenneth Shain, Rachid Baz, Melissa Alsina, and Frederick L. Locke

Subjects
Transplantation, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology
Published
2022

11. Prospective Cohort Study of Immune Suppression Taper and Discontinuation

Author

Joseph A. Pidala, Ram Thapa, Jongphil Kim, Asmita Mishra, Doris K Hansen, Rawan G Faramand, Mohamed A. Kharfan-Dabaja, Aleksandr Lazaryan, Farhad Khimani, Nelli Bejanyan, Michael L. Nieder, Taiga Nishihori, Hien Liu, Melissa Alsina, Omar Castaneda, Marco L. Davila, Hany Elmariah, Ciara Freeman, Michael D Jain, Frederick L. Locke, Leonel Ochoa, Brian C. Betts, Lia Elena Perez, Ernesto Ayala, Paula Keskula, Alexandre Albanese, Claudio Anasetti, and Leslie S. Kean

Subjects
Transplantation, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology
Published
2022

12. Allogeneic Hematopoietic Cell Transplant Outcomes for Chronic Myelomonocytic Leukemia: Single Center Experience

Author

Michael D. Jain, Taiga Nishihori, Hany Elmariah, Jeffrey E. Lancet, Eric Padron, Rawan Faramand, Asmita Mishra, M. Alsina, Joseph Pidala, Jongphil Kim, Jose Ochoa-Bayona, Aleksandr Lazaryan, David A Sallman, Nelli Bejanyan, Marco L. Davila, Hien Liu, Frederick L. Locke, Andrew T. Kuykendall, Farhad Khimani, Claudio Anasetti, Michael L. Nieder, Rami S. Komrokji, Lia Elena Perez, and Ariel Perez Perez

Subjects
Transplantation, Hematopoietic cell, business.industry, medicine, Cancer research, Molecular Medicine, Immunology and Allergy, Chronic myelomonocytic leukemia, Cell Biology, Hematology, Single Center, medicine.disease, business
Published
2021

13. Outcomes from unrelated donor hematopoietic stem cell transplantation

Author

Lia Elena Perez

Subjects
Oncology, medicine.medical_specialty, medicine.medical_treatment, Hematopoietic stem cell transplantation, Unrelated Donor, Internal medicine, medicine, Humans, Transplantation, Homologous, Sibling, Leukemia, Hematopoietic cell, business.industry, Histocompatibility Testing, Hematopoietic Stem Cell Transplantation, Hematology, General Medicine, Survival Analysis, Transplantation, Treatment Outcome, Curative treatment, Savior sibling, Feasibility Studies, business, Unrelated Donors
Abstract

Background Allogeneic hematopoietic cell transplantation (HCT) offers a curative treatment option for management of a variety of hematologic malignancies. While sibling donors have been the gold standard for adult patients in need of an HCT, not all patients have a suitable family donor. The availability of unrelated volunteer donor registries and alternative stem cell sources has expanded the wide application of this procedure. Methods PubMed and MEDLINE were searched for human trials and the English language from 2001 to 2011. Factors influencing transplantation outcomes involving unrelated donors over the last decade are discussed, and feasible alternative stem cell sources when a matched unrelated donor is not available are reviewed. Results HCT using a matched unrelated donor offers outcomes comparable to sibling HCT due to current molecular-based HLA typing and improvements in conditioning regimens and/or supportive care. The primary factor that contributes to improved outcome is the degree of donor-to-recipient HLA matching. The selection of younger unrelated donors has also been associated with improved outcomes in HCT. Evidence supports the universal application of matched unrelated donors even in high-risk leukemia and/or older patients. In adult patients without a matched related donor, other promising options as stem cell source includes mismatched unrelated donors, umbilical cord blood units, and haploidentical donors. Conclusions With current methodologies for molecular HLA typing and supportive care tools, outcomes of transplants with matched unrelated donors are comparable to those achieved with sibling donors. Alternative stem cell donors when a matched unrelated donor is not available are feasible expanding the stem cell donor pool.

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results